Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India
The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in…
Wegovy
Read More
Dr Reddy’s Plans Up to 60% Cheaper Generic Version of Wegovy as Patent Nears Expiry
India’s Dr Reddy’s Laboratories is preparing to introduce a significantly lower-priced generic version of blockbuster weight-loss drug Wegovy, currently sold…
Novo Nordisk Reduces Wegovy Prices in China Amid Rising Competition
Novo Nordisk has announced a reduction in the price of its blockbuster weight-loss drug Wegovy in China, as the Danish…
Novo Nordisk to Introduce Ozempic in India This Month
Danish pharmaceutical giant Novo Nordisk (NOVOb.CO) is preparing to roll out its diabetes medication Ozempic in India within the next…
Eli Lilly Bets Big on India’s Weight-Loss Market, IMA Warns of Drug Misuse
US pharma giant Eli Lilly is preparing to expand its footprint in India’s fast-growing weight-loss drug market. After launching its…
Eli Lilly’s Mounjaro Overtakes Novo Nordisk’s Wegovy in UK Market Leadership
Eli Lilly’s Mounjaro has emerged as the leading choice in the UK’s private obesity drug market, outperforming Novo Nordisk’s Wegovy…
Eli Lilly Prepares to Launch Obesity and Diabetes Drug Tirzepatide in India by 2025
Eli Lilly, the U.S.-based pharmaceutical giant, plans to introduce its obesity and diabetes drug Tirzepatide (marketed as Mounjaro) in India…
Novo Nordisk India Urges Early Wegovy Launch Amid Competition Concerns
Novo Nordisk’s team in India is asking the company’s global leaders to launch its weight-loss drug Wegovy earlier than planned….
Ozempic and Wegovy Linked to Rare Eye Condition Resulting in One-Eye Blindness
A recent study has identified a potential link between the popular diabetes and weight-loss drugs Ozempic and Wegovy and a…